Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2022 | Racial disparities in prostate cancer clinical trial participation and survival outcomes

Nishita Tripathi • 19 Feb 2022
GU Cancers 2022
Genitourinary Cancer Prostate Cancer Abiraterone Docetaxel

Nishita Tripathi, MD, University of Utah, Salt Lake City, UT, discusses racial disparities in prostate cancer clinical trial participation and in outcomes for prostate cancer patients. Dr Tripathi also discusses reasons for these disparities. This interview took place at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium 2022 in San Francisco, CA.

More from Nishita Tripathi

2:24
Tumor genomic landscape in younger vs older patients with mccRCC
Nishita Tripathi • 19 Feb 2022
3:09
Tumor genomic landscape of locally advanced or metastatic UC with squamous differentiation
Nishita Tripathi • 19 Feb 2022
2:44
Tumor genomic landscape in smokers compared to non-smoker patients with locally advanced or mUC
Nishita Tripathi • 19 Feb 2022

Related Videos

2:26
Prognostic factors of renal cell cancer in elderly patients
Teemu Murtola • 9 Apr 2024
2:44
The effect of hypoxia on lipid metabolism and prostate cancer tumor growth
Teemu Murtola • 9 Apr 2024
3:07
Serum thymidine kinase 1 as a predicative biomarker in prostate cancer
Teemu Murtola • 9 Apr 2024
0:57
Real-world outcomes of 177Lu-PSMA-617 in mCRPC
Hannah McManus • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals